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Effect of an acute dose of omega-3 fish oil following exercise-induced muscle damage 
 
 
Abstract 
Purpose: The purpose of this double blind, placebo controlled study was to examine the effect of 
two fish oil supplements, one high in EPA (750mg EPA, 50mg DHA and one low in EPA 
(150mg EPA, 100mg DHA), taken acutely as a recovery strategy following EIMD.  
Methods: Twenty-seven physically active males (26 ± 4 yr, 1.77 ± 0.07 m, 80 ± 10 kg) completed 
100 plyometric drop jumps to induce muscle damage. Perceptual (perceived soreness) and 
functional (isokinetic muscle strength at 600 and 1800·s-1, squat jump performance and 
countermovement jump performance) indices of EIMD were recorded before, and 1, 24, 48, 72, 
and 96h after the damaging protocol. Immediately after the damaging protocol, volunteers 
ingested either a placebo (Con), a low EPA fish oil (Low EPA) or a high EPA fish oil (High 
EPA) at a dose of 1g per 10kg body mass.  
Results: A significant group main effect was observed for squat jump, with the High EPA group 
performing better than Con and Low EPA groups (average performance decrement, 2.1%, 8.3% 
and 9.8%, respectively), and similar findings were observed for countermovement jump 
performance, (average performance decrement, 1.7%, 6.8% and 6.8%, respectively, p = 0.07).  
Significant Time, but no interaction main effects were observed for all functional and perceptual 
indices measured, although large effects sizes demonstrate a possible ameliorating effect of high 
dose of EPA fish supplementation (effect sizes ≥ 0.14).  
Conclusion: This study indicates that an acute dose of high EPA fish oil may ameliorate 
functional changes following EIMD.  
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Abbreviations: 
CK  Creatine Kinase 
CMJ  Countermovement Jump 
DHA  Docosahexaenoic Acid 
EIMD  Exercise-induced muscle damage 
EPA  Eicosapentaenoic Acid 
IL-6  Interleukin-6 
SJ  Squat Jump 
Introduction: 
Exercise-induced muscle damage (EIMD) is a well-recognised and documented condition, and 
primarily occurs as a result of unaccustomed or eccentrically biased exercise (Proske and 
Morgan, 2001). EIMD manifests through increases in localised inflammation, decreases in 
functional muscle capability and most noticeably, through increases in perceived muscle soreness 
24-72h following a damaging bout of exercise (Jakeman et al., 2009; Webb and Willems, 2010). 
These transient symptoms can be relatively debilitating, and while there may be positive long 
term adaptations elicited as a result of EIMD, those involved in the preparation of athletes for 
competition, in particular multiple competitions in a short time frame, have sought methods of 
facilitating recovery to expedite a return to optimal performance. To this end, methods such as 
cold-water immersion, massage, and active recovery have been considered (Barnett, 2006), 
although the evidence advocating the use of these treatments remains equivocal (Bailey et al., 
2007; Jakeman et al., 2009; Hilbert et al., 2003). In addition, it has been demonstrated that 
exercise which results in muscle damage can confer a protective effect on an individual, known as 
the repeated bout effect, reducing symptoms from similar future exercise as long as the exercise 
bouts in each condition are similar (Margaritelis et al., 2015).  
 
While physical therapies have shown some success in alleviating symptoms of EIMD, nutritional 
supplementation is also widely used to facilitate recovery following EIMD, with a number of 
studies considering the efficacy of non-steroidal anti-inflammatory drugs for example (Bourgeois 
et al., 1999; Paoloni et al., 2009). Omega-3 fish oil is a supplement which has increased in 
popularity as it has potent anti-inflammatory effects and is associated with a lower risk of 
coronary heart disease (Hu et al., 2002). The two primary constituents of fish oil, 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are thought to reduce the 
production and release of arachidonic acid and pro-inflammatory prostaglandins, among others, 
with this being particularly true of EPA (Tartibian et al., 2011; Lenn et al., 2002). Accordingly, it 
has been suggested that fish oil can ameliorate symptoms of EIMD, including soreness and 
swelling (Jouris et al., 2011). Typically, prolonged supplementation periods, including 7, 21, 26 
and 30 days, have been used to assess the effect of fish oil in moderating EIMD, as it has been 
demonstrated that chronic supplementation can result in EPA and DHA being incorporated into 
cellular membranes (Jouris et al., 2011; Houghton and Onambele, 2012; Mickleborough et al., 
2015; Lembke et al., 2014; Lenn et al., 2002). Recent research has concluded that EPA and DHA 
supplementation in a 2:1 ratio may be beneficial to attenuating symptoms of EIMD when 
consumed chronically (8 weeks; Tsuchiya et al., 2016). While these findings are of practical 
interest, anecdotal evidence suggests that individuals consume fish oil immediately post-exercise 
in an attempt to ameliorate symptoms of EIMD. There is currently little evidence to support this 
approach. As such, research into the effects of acute supplementation, in respect to real-world 
practices, is warranted, particularly in order to guide athletes and coaches intending to maximize 
recovery following strenuous exercise. 
 
The purpose of this study was therefore to examine the efficacy of an acute dose of omega-3 fish 
oil on recovery following EIMD. It was hypothesized that an acute dose of omega-3 fish oil 
would aid recovery following EIMD, and that a high dose of EPA would have a greater effect 
than a low dose of EPA. 
 
Methods 
Participants 
For this double blind, placebo controlled study, twenty-seven physically active (> 3h.wk-1 of 
vigorous athletic training involving repeated bouts of high-intensity intermittent training) men 
volunteered to participate (26 ± 4 yr, 1.77 ± 0.07 m, 80 ± 10 kg). Participants were injury free, 
healthy and asymptomatic of any illness, as confirmed through health screening procedures 
(ACSM 2013), and were excluded if they had engaged in specific lower limb eccentric or 
plyometric training in the previous 6 months. Volunteers were asked to refrain from any 
exhausting physical activity or from using any additional form of recovery method (e.g., ice, 
massage, nutritional supplements) in an attempt to attenuate the negative effects of EIMD during 
their participation in this study. The study was conducted in agreement with the policies and 
guidelines of the institutional Human Ethics Committee, and informed consent was obtained from 
all individual participants included in the study. A priori calculations of statistical power indicated 
that this sample size was appropriate to satisfy power at or above 80% (Jakeman et al., 2010).  
 
Procedures 
Following the collection of anthropometric data, participants completed an exercise protocol 
designed to induce muscle damage. Following this, participants were randomly assigned to one of 
three Groups: High EPA (n = 9; age 25.5 ± 5.2 y, height 1.74 ± .06 m, weight 76.5 ± 12.6 kg), 
Low EPA (n = 9; age 25.6 ± 4.8 y, height 1.82 ± .09 m, weight 80.2 ± 12.0 kg) or placebo (n = 9; 
age 26.2 ± 4.2 y, height 1.78 ± .01 m, weight 82.9 ± 12.1 kg). Physiological and perceptual 
characteristics were assessed in the following sequential order, prior to- (baseline [BL]) and 
following (1, 24, 48, 72 and 96 h) the EIMD protocol: myofibre protein concentration (plasma 
creatine kinase [CK]), inflammatory markers (Interleukin 6 [IL-6]), perceived muscle soreness, 
countermovement and squat jump height and isokinetic muscle strength (maximal knee 
extension). Data were collected 1 h after damaging exercise in order to provide an indicator of the 
magnitude of immediate muscle damage, without the confounding factor of acute fatigue 
resultant from the muscle damaging protocol. 
 
 
Plyometric exercise protocol 
To induce muscle damage, participants performed 10 x 10 repetitions of plyometric drop jumps, 
with 10 s separating each jump, and 60 s recovery between sets, beginning after completion of the 
tenth jump of each set. Under the guidance of an experienced strength and conditioning coach, 
participants were asked to step from a 0.6 m high box, land (with both feet) in a squat position, 
with approximately 90° of hip and knee flexion, and then perform a maximal vertical jump in a 
continuous movement. This protocol has been used successfully elsewhere (Highton et al., 2009). 
 
Randomisation 
On completion of the plyometric exercise protocol, participants were randomised into one of three 
Groups: Con - participants received placebo capsules which consisted of filler oil, flavour masker 
and gelatine; High EPA – participants consumed 1g·10 kg body mass of fish oil capsules; EPA 
750mg, DHA 50mg; Low EPA – participants consumed 1g·10 kg body mass of fish oil capsules; 
EPA 150mg, DHA 100mg). All supplements were provided in 1g capsules, and given to 
participants in one dose upon completion of the plyometric protocol. Allocation to groups was by 
means of sealed envelopes drawn by the participants, designed for an equal allocation between the 
three groups. A researcher who was not involved in data collection provided capsules, while data 
analysts were blinded from the grouping code.  
 
Assessment of EIMD 
Jump performance  
Squat and countermovement jump height was assessed using a vaned jump and reach apparatus, 
which provides the maximum height reached to the nearest centimetre (Yardstick, Swift Systems, 
Lismore, Australia), with the best of three attempts being recorded in accordance with previous 
research (Ali et al., 2011; Pournot et al., 2011). Each jump was completed after verbal command 
and demonstration, with a minimum of one-minute between jumps, following the protocol of 
Jakeman et al. (2010). Participants were given time prior to beginning the experimental procedure 
to familiarise themselves with this apparatus and jump procedures. Typical CV% for these 
measures within our lab is 3-3.5% for these jumps. 
 
Isokinetic muscle strength 
Dynamic muscle function was assessed using isokinetic dynamometry. Participants were seated 
upright with the upper body and experimental leg secured to reduce extraneous movement. The 
axis of rotation of the knee of the dominant leg was aligned with the dynamometer which was 
maintained throughout the testing period. Each participant’s body position was recorded and 
replicated for subsequent tests. Participants completed five maximal voluntary isokinetic 
concentric contractions at 600 and 1800·s-1 through approximately a 90° range of movement from 
90° knee flexion on the dominant leg. The best of five maximal gravity-corrected concentric 
contractions (Biodex 3 Medical Systems, New York, USA) of the knee extensors was taken as the 
criterion measure of muscle strength. 
 
Perceived muscle soreness:  
Perceived soreness was assessed using a 10 cm visual analogue scale, with 0 (no pain) and 10 
(worst pain ever) at the two extremes. Participants were instructed to assume an un-weighted 
squat of approximately 90° and mark their perceived soreness on a horizontal line between 0 and 
10 (Twist and Eston, 2005). 
 
Blood markers:  
A 6 ml venous blood sample drawn from the antecubital vein at each time point, and was 
centrifuged (Medifuge, Heraeus Sepatech, Germany) for 10 min to obtain plasma samples 
(Woolley et al., 2014), which were frozen at -80°C until analysis. Automated spectrophotometry 
(Cobas 6000, Roche Diagnostics, Indianapolis, USA) was used to analyse samples for plasma CK 
concentration, and an ELISA kit (Enzyme Linked Immuno Sorbent Assays, Enzo Life Sciences, 
New York, USA) with a sensitivity of 6.01 pg·ml and specific for bioactive human IL-6 was used 
to measure Interleukin-6. 
 
Statistical analysis 
Data for creatine kinase and IL-6 were log transformed to address assumptions of sphericity, and 
all performance data were analysed as a proportion of baseline (%). A series of two-factor 
repeated-measures analysis of variance; Group (High EPA, Low EPA, Con) by Time (BL, 1, 24, 
48, 72 & 96 h) were used to analyse data. The Mauchly sphericity test was used to test 
assumptions of homogeneity of variance. If this was violated, the Greenhouse-Geisser value was 
used to adjust degrees of freedom to increase the critical value of the F ratio. Effect sizes were 
reported as partial eta-squared (η2p), whereby by 0.01, 0.06 and 0.14 represented a small, medium 
and large effect (Cohen, 1988). Alpha was set at 0.05 throughout all analyses, and all data were 
analysed using the statistical package SPSS for Windows, PC Software, version 22. 
 
 
 
 
Results 
  
Jump performance 
A significant main effect for Time was observed for both squat jump (F3,77 = 14.4, p < 0.001, η
2
p 
0.38) and countermovement jump performance (F2.9,70 = 10.5, p < 0.05, η
2
p 0.31), whereby the 
significant decreases in performance which were observed at 1 h were maintained until 96 h post-
EIMD (Figure 1). A significant Group effect was also observed for Squat jump performance 
(F2,24 = 7.5, p < 0.05, η
2
p 0.39), with the High EPA group performing significantly better than 
either the Low EPA or Con groups. Although non-significant, a similar trend was observed for 
countermovement jump performance (F2,24 = 3.19, p = 0.07, η
2
p 0.2). There was no Group x Time 
interaction for either squat- or countermovement jump performance (p > 0.05), however, a large 
effect was observed (both eta = 0.13).  
 
Insert figure 1 here  
 
Fig. 1 Squat (A) and countermovement (B) jump performance before and up to 96h after 
damaging exercise 
 
*Denotes a significant group effect 
 
 
Isokinetic muscle strength 
A significant Time main effect was observed for knee extensor strength at both 600·s-1 (F5,120 = 
25.7, p < 0.05, η2p 0.52) and 180
0· s-1 (F5,120 p < 0.05, η
2
p 0.42; Figure 2). There was a significant 
reduction in strength at 1 h at both 600 and 1800·s-1, which persisted for 96 h and 72 h respectively 
following damaging exercise. There were no differences between Groups (F2,24 = 1.9, p > 0.05, 
η2p = 0.14 ; F2,24 = 0.4, p > 0.05, η
2
p 0.31 for 60
0 and 1800·s-1 respectively), nor any Group by 
Time interactions (F10,120 = 1.5, p > 0.05, η
2
p 0.11 and F10, 120 = 0.62, p > 0.05, η
2
p 0.05 for 60
0 
and 1800·s-1 respectively).  
 
Insert figure 2 here  
 
Fig. 2 Isokinetic muscle strength at 600.s-1 (A) and 1800.s-1 (B) before and up to 96h after 
damaging exercise 
 
Perceived muscle soreness 
There was a significant main effect for Time (F2.5, 60.5= 36.6, p < 0.05, η
2
p 0.60), but no Group 
(F2,24 = 0.69, p > 0.05, η
2
p 0.05) or Group x Time interaction (F5, 60.5 = 1.05, p > 0.05, η
2
p 0.08). In 
all Groups, perceived soreness peaked 24 h following EIMD, and recovered to baseline values at 
96 h (Figure 3). 
 
Insert figure 3 here 
 
Fig. 3 Perceived muscle soreness before and up to 96h after damaging exercise 
 
 
Myofibre proteins  
There was a significant Time main effect for creatine kinase concentration (F1.6,36 = 13.9, p < 
0.05, η2p 0.38, but no Group or Group x Time interaction (F2,22 = 1.6, p > 0.05, η
2
p  0.12 and 
F3.2,36 = 0.143, p > 0.05, η
2
p 0.13 respectively). There were no Time (F2.2,41.8 = 1.04, p > 0.05, η
2
p 
0.052) Group (F2,22 = 0.225, p > 0.05, η
2
p 0.12) or Group x Time interaction effects (F3.2,36 = 
0.143, p > 0.05, η2p 0.013) for IL-6 following EIMD (Table 1). 
 
Insert table 1 here 
 
Table 1 Creatine kinase and IL-6 concentration before and up to 96h after damaging exercise. 
Data presented as mean (± sd) 
 
 
 
Discussion 
This study assessed whether an acute dose of omega-3 fish oil immediately following strenuous, 
eccentrically biased exercise would moderate symptoms of EIMD. The current study shows that 
acute ingestion of omega-3 fish oil, in particular a supplement which is high in EPA, is beneficial 
to some markers of exercise performance following EIMD, in comparison with either a low dose 
EPA supplement, or a placebo. While many studies have investigated the efficacy of omega-3 
fish oil as a recovery strategy following EIMD, to our knowledge, this is the first study to 
consider a large, acute dose of omega-3 in such a manner. To facilitate the practical applicability 
of the current work and descriptive usefulness, we have included both effect sizes and confidence 
intervals relating to the collected data (Richardson, 2011). While statistical significance is 
important, in studies with small samples sizes such as those often seen in the sport and exercise 
science area, consideration of the magnitude of effect is sometimes more useful for the full 
evaluation of data (Rhea, 2004).  
 
It is well established that physical performance is detrimentally effected by EIMD, with a number 
of studies showing reductions in peak power generation, jump performance and time trial exercise 
(Byrne and Eston, 2002; Twist and Eston, 2005; Burt and Twist, 2011). Consistent with our 
hypothesis as indicated in Figure 1a, and when observing a large effect size (η2p 0.39), high dose 
EPA supplementation attenuated the decrement in average squat jump performance (-2.1%) in 
comparison to both low dose EPA (-9.8%) and placebo (-8.3%) supplementation. Importantly, 
participants in the High EPA group had recovered to within ~2% of baseline performance at 24 h, 
whereas participants in the Low EPA or Con groups remained ~12% lower than baseline 
performance at 24 h. From a practical perspective, the impairment in squat jump performance at 1 
h in the High EPA group was equivalent to the impairment observed at 96 h for both the Low 
EPA and placebo groups, indicating a faster recovery of performance capability. A similar pattern 
was also observed with countermovement jump performance (average decrement of 1.7%, 6.8% 
and 6.8% in High EPA, Low EPA and Con respectively; η2p 0.2). For example, the decrement in 
performance was only 4% after 1 h for the High EPA group in comparison with the 10.1% and 
15% decrements observed for the Con or Low EPA groups respectively. Similar to the changes in 
squat jump performance, the High EPA group returned to within 2% of baseline performance 
after 24 h, in comparison with the Control and Low group, whereby there countermovement jump 
performance was still 4.4 and 3.8% below baseline at their 96 h re-assessment (Figure 1b).    
 
It is widely agreed, that one of the initial consequences of EIMD is harm to the contractile 
machinery of the muscle, manifest by the disruption of sarcomeres, which is thought to prevent 
the muscle from contracting normally (Proske and Morgan, 2001). Squat jump exercise relies 
heavily on muscle contractile properties by limiting as much as possible, the influence of the 
stretch shortening cycle. Therefore, reductions in squat jump performance are likely to be related 
to an inability to contract musculature due to the bout of damaging exercise. Reductions in 
contractile force capability are compounded by the possibility that voluntary muscle activation is 
negatively affected by EIMD (Prasartwuth et al., 2005). However, Prasartwuth et al. (2005) 
suggest that reductions in maximal voluntary muscle activation may be a partial cause of initial 
force loss. The countermovement jump in this case relies on the influence of the stretch-
shortening cycle, as well as the contractile machinery and therefore, changes in neural factors are 
likely to have a compounding effect on performance. With the current data showing an immediate 
protective effect in the High group, it is therefore possible that supplementation allowed for 
greater voluntary activation, a suggestion supported by Lewis et al. (2015). In their study, 
although their findings were not in relation to EIMD, Lewis and colleagues reported that 
peripheral neuromuscular function may be improved in experimental athletic situations as a result 
on consumption of omega-3. 
 
When considering the isokinetic muscle function at 600 and 1800.s-1, despite no statistical 
differences between groups, large effect sizes were noted (0.14 and 0.31, respectively). Average 
performance changes at 600 and 1800.s-1 were similar to changes in the squat and 
countermovement jump respectively, and may reflect similar speed characteristics between these 
measures. Again, changes in performance at 600.s-1  are likely to be due to a reduced ability of the 
contractile machinery used at this relatively slow movement speed. The pattern of change in 
performance at 1800 was similar in all groups, and while there was no statistically significant 
difference in group, there is a trend toward a protective effect at 600.s-1. The large effect sizes 
here indicate that for 72 h after damaging exercise, individuals in the high group seemed to 
experience a lower reduction in performance (Figure 2). It is worth noting that isokinetic muscle 
function was analysed concentrically, in order to be more relevant to the prime mover muscles 
involved in many sporting activities, such as running and jumping (McBride et al., 2008). 
However, it is possible that the eccentric damaging protocol would have been more pronounced 
on an eccentric isokinetic movement pattern, and given that eccentric muscle movements are 
imperative for movement stability (LeStayo et al.,2003), future studies may find it interesting to 
consider eccentric muscle function assessment, in place of or in addition to concentric muscle 
function assessment, particularly where injury is a primary topic of interest. 
 
One of the most noticeable effect of EIMD is delayed onset muscle soreness (DOMS), which may 
be associated with an increase in swelling resulting from the bout of damaging exercise (Miller et 
al., 2004). While this is a normal process of recovery and adaptation within the body, symptoms 
of EIMD such as DOMS are detrimental to performance in athletic situations. While there is 
benefit to physical activity which results in EIMD (see McHugh 2003 for example), individuals 
involved in regular and repeated competition in a short time period (i.e., tournament play) may 
wish to forgo any positive adaptive effects in favour of being able to maintain optimal athletic 
performance. As a result of studies demonstrating an anti-inflammatory effect of omega-3 
(Tartibian et al., 2011; Mickleborough et al., 2015), it was hypothesised that IL-6, and perceived 
muscle soreness may have been reduced in the High and Low EPA groups. Although not 
conclusive (Weldon et al., 2007), EPA has been shown to be a more potent inhibitor of the 
inflammatory response than DHA (Mickleborough et al., 2009), and it may have been expected 
that this would result in the high EPA group having reduced symptoms of inflammatory markers. 
Such findings were not evident in the present study as similar perceptions of muscle soreness and 
inflammatory markers were observed between groups. While this is in contrast to other studies 
which have considered similar scenarios (Jouris et al., 2011), the lack of impact on perceived 
muscle soreness reflects work by Lenn et al. (2002) and Houghton and Onambele (2012). It is 
likely that the lack of effect in the current work was due to the nature of the supplementation, in 
the fact that it was an acute, rather than a chronic supplementation protocol. Prolonged ingestion 
of omega-3 fish oil has been shown to result in changes to muscle cell membrane, altering its 
permeability and making the cell less susceptible to EIMD. Tartibian et al. (2009), for example, 
reported reduced perceived soreness following strenuous eccentric exercise in a group 
supplementing for 30 days with omega-3. The authors suggested that this may be due to a 
decrease in muscle damage or reduction in inflammation experienced by the supplementing 
group, in comparison with both a placebo group, and a non-supplementing control, and is a theme 
which has been reported elsewhere (Tsuchiya et al., 2016). Given that the current study employed 
an acute dose of omega-3, it may have had little effect on inflammatory markers immediately 
after damaging exercise, but may have been influential in promoting recovery at later time points. 
Previous research by Gingras et al. (2007) has indicated that ingestion of omega-3 oils can alter 
protein synthesis and insulin sensitivity, and positive alterations in anabolic responses have also 
been reported by Smith and colleagues (2011a; 2011b) in human models. This suggests that 
omega-3 fatty acids can stimulate muscle protein synthesis, which may also have influenced the 
recovery process, however further study would be required to determine this. Although there 
were no indications that inflammatory markers had been affected by the treatment, it is worth 
noting that some inflammatory markers, particularly creatine kinase, relate poorly to the 
magnitude or time-course of EIMD as indicated by other markers (for review, see Warren et al., 
1999). While not measured, it is possible that a reduction in actual swelling of the affected limbs 
may have been reduced by the treatment, and therefore contribute to the differences in response 
observed on the performance measures.  
 
As noted previously, the supplementation strategy used in the current study is very different to 
that used by others, in that it focuses on an acute, large dose supplementation. Recently, Tsuchiya 
et al. (2016) investigated the use of a ratio of EPA:DHA of approximately 2:1, with participants 
ingesting 600 mg EPA and 260 mg DHA each day for 8 weeks. Participants in the current study 
consumed either 15:1 or 1.5:1 EPA:DHA ratio immediately after EIMD, which was relativised 
for body mass, an important consideration which has also not been previously made. While it 
appears that the high group (15:1 EPA:DHA) experienced an enhanced recovery, the mechanisms 
responsible for this were not investigated in the current study, and should be considered in future 
work. As a result of the novel dosing strategies (an acute dose relative to body mass) it makes the 
comparison of the current results with other similar studies problematic, and further research on 
the areas of dose, duration and body mass/composition should be considered.  
 
Conclusions 
In conclusion, this double-blind, placebo controlled study has demonstrated that a high dose of 
high EPA omega-3 fish oil immediately following strenuous, eccentrically biased exercise may 
moderate symptoms of EIMD. While statistically non-significant, the large effect sizes observed 
suggest that a number of the considered performance measures were positively influenced by the 
High but not the low EPA dose. During both the squat and countermovement jump, the 
performance decrement in those individuals taking the high dose omega-3 fish oil was 
significantly attenuated, nearly returning to their baseline level of performance within 24 hours. 
While these findings are of practical interest, further research is needed in order to determine 
optimal supplementation strategies, both in terms of duration and dose, as well as the optimal 
EPA:DHA ratio. 
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  Time 
 Condition Baseline 1hr 24hr 48hr 72hr 96hr 
CK (u.L) 
 
A 189.1 (116.2) 
229.2 
(126.5) 
419.1 
(194.8) 
278.4 
(120.5) 
195.0 
(79.3) 
216.3 
(153.5) 
B 311.1 (200.8) 
372.0 
(189.2) 
627.3 
(451.1) 
457.6 
(401.6) 
430.1 
(577.2) 
401.4 
(538.9) 
C 182.3 (123.0) 
232.6 
(124.1) 
450.4 
(286.6) 
266.4 
(120.5) 
204.9 
(110.1) 
164.8 
(69.0) 
IL-6 
(pg/ml) 
 
A 7951.1 (3684.3) 
8195.7 
(3812.0) 
8179.3 
(3680.1) 
8103.3 
(3794.3) 
8059.8 
(3553.9) 
8092.4 
(3559.9) 
B 5528.0 (2882.5) 
5534.2 
(2533.9) 
5751.6 
(2944.1) 
5528.0 
(2315.7) 
5254.7 
(2139.4) 
5652.2 
(2600.2) 
C 
 
6267.1 
(2525.2) 
5913.1 
(1766.5) 
5472.0 
(2216.7) 
5484.5 
(1912.8) 
5130.4 
(2070.4) 
5987.6 
(2765.9) 
 
Table 1. Blood table 
  
 
Fig 1. Squat (a) and countermovement (b) jump performance before and up to 96h after damaging 
exercise. * denotes a significant group effect 
 
 
 
 
  
Fig 2. Isokinetic muscle strength at 60° s-1 (a) and 180° s-1 (b) before and up to 96h after damaging 
exercise 
 
 
 
 
  
Fig 3. Perceived muscle soreness before and up to 96h after damaging exercise 
 
 
